| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner | Director, 10% Owner
6 companies
Polaris Venture Management Co. V, L.l.c. is a 10% Owner at Cardlytics, Inc. with holdings across 6 companies. Recent SEC Form 4 filings include 12 buys and 64 sells.
Estimated insider holdings value: $447K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 5, 2020 | LYRA Lyra Therapeutics, Inc. | 10% Owner | Buy | 62,500 | $16.00 | $1,000,000.00 | +6.0% | |
| May 5, 2020 | LYRA Lyra Therapeutics, Inc. | 10% Owner | Sell | 9,674 | $16.00 | $154,784.00 | -0.9% | |
| Jul 17, 2019 | CDLX Cardlytics, Inc. | 10% Owner | Sell | 68,727 | $27.66 | $1,900,767.37 | -1.0% | |
| Jun 7, 2019 | CDLX Cardlytics, Inc. | 10% Owner | Sell | 100,000 | $25.62 | $2,562,120.00 | -4.2% | |
| Jun 6, 2019 | CDLX Cardlytics, Inc. | 10% Owner | Sell | 75,284 | $24.10 | $1,814,073.25 | -0.6% | |
| May 28, 2019 | CDLX Cardlytics, Inc. | 10% Owner | Sell | 100,000 | $23.04 | $2,303,810.00 | -3.9% | |
| Sep 13, 2018 | CDLX Cardlytics, Inc. | Director, 10% Owner | Sell | 150,000 | $25.04 | $3,756,280.86 | -1.4% | |
| Nov 20, 2017 | XFOR X4 Pharmaceuticals, Inc | 10% Owner | Buy | 500,000 | $10.00 | $5,000,000.00 | +36.5% | |
| Jun 27, 2016 | RNAC Cartesian Therapeutics, Inc. | 10% Owner | Buy | 150,000 | $14.00 | $2,100,000.00 | +8.6% | |
| Feb 2, 2015 | OCUL Ocular Therapeutix, Inc | 10% Owner | Sell | 500,000 | $29.50 | $14,750,000.00 | -19.8% |